Tomas Kiselak
Director at Oruka Therapeutics, Inc. (ORKA); Director at Zenas BioPharma, Inc. (ZBIO)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return+24.7%
vs. S&P 500+10.4%
Beat the market100%
Paper profit on buys+$1.1M
Total bought / sold$3.0M / $300M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 1SEC | ORKAOruka Therapeutics, Inc. | Sell | 3,553,4101,131,954 held (−76%) | $84.43 | $300M | -2.7% |
| Apr 1SEC | ZBIOZenas BioPharma, Inc. | Buy | 150,0002,359,025 held (+7%) | $20.00 | $3.0M | +36.3% |
- Sell
Director Tomas Kiselak sold $300M of ORKA at $84.43 — cuts the stake by 76%.
- Buy
Director Tomas Kiselak bought $3.0M of ZBIO at $20.00 — first open-market purchase in our records.